We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for iptacopan (Novartis Pharmaceuticals Australia Pty Ltd)
Active ingredients
iptacopan
Date of review outcome
Lapse date
Type
Priority review
Indication
Treatment of adult patients with complement 3 glomerulopathy (C3G)
Therapeutic area
Nephrology